Skip to main content

Table 2 General distribution of patients with diabetes mellitus by primary care center (PCC).

From: Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain

Variables PCC-1 n = 978 PCC-2 n = 1,486 PCC-3 n = 902 PCC-4 n = 774 p
CVD (events, %) 22.2 20.7 20.0 21.1 ns
Use of ASA (%) 29.1 35.3 20.0 28.2 0.000
Sex (males, %) 46.9 51.5 46.8 50.9 0.041
Mean age (SD), years 62.2 (14.2) 64.1 (13.5) 65.5 (13.5) 64.9 (13.9) 0.000
CV history      
Hypertension 49.4 51.2 55.8 50.0 0.002
Hypercholesterolemia 35.8 39.5 37.7 36.2 ns
Active smoking 21.6 17.7 18.3 17.2 ns
Obesity (BMI < 29) 48.5 46.9 46.4 43.9 ns
Therapeutic targets      
BP (<130/80 mmHg) 49.6 37.4 50.1 57.6 0.002
Total cholesterol (<200 mg/dL) 50.6 50.7 41.1 45.0 0.000
LDL-C (<100 mg/dL) 20.6 21.7 13.5 17.1 0.000
Glycated HbA1c (<6.5%) 33.3 34.4 32.0 33.6 ns
  1. Values are given as percentage or mean (SD: standard deviation); p: statistical significance; CVD: cardiovascular disease; ASA: acetyl salicylic acid; CV: cardiovascular; BMI: body mass index; BP: blood pressure (mmHg); LDL-C: low density lipoprotein cholesterol (mg/dL); Hb: hemoglobin.